Managing Patients with Schizophrenia: Provider and Payer Considerations

John J. Miller, MD, and Nev Jones, PhD, open a discussion providing an overview on the current state of patients with schizophrenia.

Carlos Larrauri, APRN, details the signs and symptoms necessary to make a schizophrenia diagnosis.

Social determinants of health impacting the treatment landscape for schizophrenia are discussed.

A panel of medical experts discuss the clinical and financial considerations surrounding the treatment of patients diagnosed with schizophrenia.

Sandy Dimiterchik, an advocate for patients diagnosed with schizophrenia, leads the panel in a discussion highlighting barriers that inhibit optimal patient care.

Dr Carney opens a discussion around factors impacting schizophrenia in patients.

Panelists provide insight into the standards of care for treating patients diagnosed with schizophrenia.

Dr Carney drives a discussion surrounding optimal treatment strategies for schizophrenia.

The use of cognitive behavioral therapy (CBT) in schizophrenia treatment is examined.

Navigating the efficacy of schizophrenia treatment selection.

Payer considerations for evaluating treatment costs in schizophrenia care are addressed by Caroline P. Carney, MD, MSc, FAPA, FAPM, CPHQ.

Panelists discuss the impact of pandemic-influenced process changes and shifting standards of care for the treatment of schizophrenia.

Future therapies for the treatment of schizophrenia are explored by a panel of key opinion leaders.

The panel provides their closing thoughts as they examine the stigmas and unmet needs surrounding schizophrenia.